Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

FSD Pharma Inc C.HUGE

Alternate Symbol(s):  HUGE

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.


CSE:HUGE - Post by User

Bullboard Posts
Post by M416416on Nov 30, 2018 2:57pm
124 Views
Post# 29046929

AUSA/HUGE

AUSA/HUGE

AUSA got around 113 million outstanding
HUGE 1.4 billion oustanding shares

AUSA just completed PP @ 2.03

AUSA/HUGE cash balance is almost same...but look at AUSA/HUGE outstanding shares...big big difference...

AUSTRALIS COMPLETES $30 MILLION PRIVATE PLACEMENT

Australis Capital Inc. has closed its previously announced non-brokered private placement of units for gross proceeds of $30-million. In order to accommodate oversubscriptions, the company also intends to increase the size of the private placement by an additional $2-million to be completed in a second tranche.

Pursuant to the private placement, Australis Capital issued 14,778,325 units at $2.03 per unit. Each unit consists of one common share in the capital of the company and one-half of a common share purchase warrant. Each whole warrant entitles the holder to purchase one additional share at a price of $2.64 on or before Oct. 25, 2020. In the event that the daily volume-weighted average trading price of the shares is greater than $3.43 for any 10 consecutive trading days, Australis Capital may accelerate the expiry of the warrants.

 

 

always looking for new trading plays....

 

Bullboard Posts